Safety and Performance Study of the CyPass System Applier Model 241

Transcend Medical, Inc.172 enrolled

Overview

This is a retrospective chart review of cases in which the CyPass Micro-Stent was implanted using the Model 241 Applier. The objective of this study is to characterize and evaluate the safety of the Model 241 Applier when used for CyPass Micro-Stent implantation.

Study Type

OBSERVATIONAL

Enrollment

172

Conditions

Open Angle Glaucoma (OAG)

Eligibility

Sex: ALLMin age: 21 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Diagnosis of OAG 2. CyPass Micro-Stent implantation (using the CyPass system 241) following uncomplicated phacoemulsification cataract removal and intraocular lens implantation Exclusion Criteria: 1. Diagnosis of acute angle closure, traumatic, congenital, malignant, uveitic or neovascular glaucoma 2. Prior incisional glaucoma surgery

Locations (1)

Klinik for Augenheilkunde - Dietrich Bonhoeffer Klinikum

Neubrandenburg, Germany

Outcomes

Primary Outcomes

Ocular adverse events in the study eye

Time frame: Intraoperatively though the first 3 postoperative months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.